Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results save search
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
Published: 2024-03-05 (Crawled : 15:00) - biospace.com/
APVO | $0.6826 -7.28% -7.84% 560K
|
Health Technology
|
| O: 4427.49%
H: 0.0%
C: -11.13%
business update therapeutics financial results
TransCode Therapeutics Announces Positive Results in Non-human Primates with its Lead Therapeutic Candidate, TTX-MC138
Published: 2023-07-31 (Crawled : 11:00) - globenewswire.com
RNAZ | $0.4399 -4.35% -1.75% 90K
|
Professional, Scientific, and T...
|
| O: 3986.21%
H: 1.43%
C: -7.17%
mc138 ttx-mc138 positive therapeutics results
Katapult to Announce Second Quarter 2023 Financial Results on August 9, 2023
Published: 2023-07-26 (Crawled : 20:00) - globenewswire.com
KPLT | $9.25 3.7% 3.57% 6.7K
|
Real Estate and Rental and Leas...
|
| O: 2368.75%
H: 5.01%
C: -3.8%
financial results
Neovasc to Report First Quarter Financial Results on May 12, 2022
Published: 2022-04-29 (Crawled : 13:20) - globenewswire.com
NVCN | $30.03 1.66% -2.02% 0
|
Health Technology
|
| O: 2289.74%
H: 0.0%
C: 0.0%
report results
Avinger to Announce Full-Year 2021 Results on March 22
Published: 2022-03-15 (Crawled : 12:30) - biospace.com/
AVGR | $3.7 0.27% 1.34% 2.9K
|
Health Technology
|
| O: 1724.4%
H: 0.0%
C: 0.0%
results
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-16 (Crawled : 12:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1599.62%
H: 4.16%
C: -5.48%
results
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 11:00) - globenewswire.com
SYBX | $1.87 -2.09% -0.53% 19K
|
Health Technology
|
| O: 1406.8%
H: 1.37%
C: 0.87%
business update financial results
Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
Published: 2023-08-07 (Crawled : 14:00) - biospace.com/
VTGN | $4.72 -2.28% -1.68% 150K
|
Health Technology
|
| O: 1090.48%
H: 0.0%
C: 0.0%
ph94 positive spray trial results
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP 5 d | $3.12 2.3% 1.93% 98K
|
Manufacturing
|
| O: 895.97%
H: 14.34%
C: 11.7%
business year update pharmaceuticals financial results
Novan Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-11 (Crawled : 23:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 895.67%
H: 5.22%
C: -3.48%
financial results results
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
Published: 2023-09-28 (Crawled : 10:00) - globenewswire.com
BNOX | $0.9469 2.57% -4.33% 25K
|
n/a
|
| O: 480.71%
H: 12.06%
C: -41.08%
bnc210 positive topline trial results
Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
SLNO | $39.34 -1.99% -1.97% 340K
|
Health Technology
|
| O: 374.04%
H: 44.29%
C: 27.62%
positive therapeutics results study
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results
Published: 2023-06-06 (Crawled : 10:00) - intellipharmaceutics.com
IPCIF | $0.06 -50.0% -29.49% 5
|
Health Technology
|
| O: 350.0%
H: 0.0%
C: 0.0%
year results
Madrigal Announces Positive Topline Results from the Pivotal Phase 3 MAESTRO-NASH Clinical Trial of Resmetirom for the Treatment of NASH and Liver Fibrosis
Published: 2022-12-19 (Crawled : 13:00) - biospace.com/
MDGL | $204.65 -6.29% -6.78% 580K
|
Health Technology
|
| O: 219.37%
H: 0.0%
C: 0.0%
treatment fibrosis liver topline trial positive nash
Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th
Published: 2022-12-18 (Crawled : 00:00) - globenewswire.com
MDGL | $204.65 -6.29% -6.78% 580K
|
Health Technology
|
| O: 219.37%
H: 0.0%
C: 0.0%
pharmaceuticals topline results study
Clubhouse Media Group, Inc. Reports 2023 Financial Results, Highlighting Increased Revenue and Decreased Expenses
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
CMGR | $0.0003 -50.0% 77K
|
Health Care and Social Assistan...
|
| O: 200.0%
H: 0.0%
C: -33.33%
media revenue financial
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
Published: 2024-02-26 (Crawled : 14:30) - biospace.com/
AKLI | $0.248 3.77% 4.02% 150K
|
|
| O: 193.1%
H: 13.69%
C: -30.36%
endeavorrx japan positive adhd trial results
BeyondSpring Announces Positive Topline Results from its DUBLIN-3 Registrational Trial of Plinabulin in Combination with Docetaxel for the Treatment of 2nd/3rd Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Wild Type
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
BYSI | $2.43 6.11% 6.91% 97K
|
Health Technology
|
| O: 191.8%
H: 6.76%
C: -5.41%
treatment lung cancer positive results cancer topline trial plinabulin
Avricore Health Corporate Updates on Audited Results for 2022
Published: 2023-05-02 (Crawled : 12:00) - globenewswire.com
AVCRF | $0.1056 207.83% 200
|
Health Technology
|
| O: 182.54%
H: 0.0%
C: 0.0%
health results
Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb
Published: 2022-12-07 (Crawled : 12:20) - globenewswire.com
RXDX | $199.92 0.02% 1.9M
|
Professional, Scientific, and T...
|
| O: 181.13%
H: 0.0%
C: 0.0%
pra023 enabling positive phase 2b
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.